ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Conference On Delayed Consequences Of Cancer Therapy Scheduled Jan. 9-11

January 3, 1975

NCI Puts Aside Fear Of Brockovich Factor To Open New Web Site On Mortality Data.

April 20, 2001

Contracting Dispute and Software Bugs Plague NCI’s $200 Million Bioinformatics Venture

February 25, 2011

Prevention Clinical Trials Heads Greenwalk Priority Lists For ‘86

February 8, 1985

New Safety Concerns On ESAs Prompt FDA To Consult ODAC Again.

January 11, 2008

In Brief: Metcalf, Sachs, Nowell, Rowley, Elkind Win 1989 GM Award; Ray Morrison Retires

June 16, 1989